Crucially, germ-free mice are incapable of producing TMAO [43]
Act 3: The Stacking Question What Longevity Experts Say About Combining Both The most sophisticated practitioners in the longevity space don't typically ask, "Should I use GLP-1 or BPC-157?" Instead, they ask, "When does each one belong in a protocol, and can they safely coexist?" The Complementary Logic Longevity-focused physicians and sports medicine practitioners have begun articulating a clear rationale for combining these compounds in specific patient profiles: The GLP-1 Layer: Addresses the metabolic side (reducing fat, improving insulin, lowering cardiovascular risk)
With a lot of peptide and little water the solution becomes very concentrated, so the volume per dose is tiny and hard to read
The majority of patients who experience side effects after their first injection find that these symptoms are mild, manageable, and improve significantly within the first week as physiological adaptation occurs
In a pooled analysis of multiple short-term, placebo-controlled studies of CNS stimulants, psychotic or manic symptoms occurred in approximately 0.1% of CNS stimulant-treated patients compared to 0% of placebo-treated patients
Compared with traditional live probiotics, postbiotics offer advantagesdefined composition, improved stability, potentially greater safety, and more tractable mechanisms of actionyet they also have inherent limitations (Pattapulavar et al., 2025)